Chronic Kidney Disease Trial, Recruiting NCT06286748 Sponsor: Universidade Federal Fluminense Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06286748
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have chronic kidney disease (CKD) at a moderate to severe stage (stages G3a to G4) and are being managed without dialysis
  • People aged between 18 and 65 years old
  • People who have been receiving dietary or nutritional monitoring for more than 6 months

Who may not be able to join:

  • People who take medications that break down muscle or tissue (catabolic drugs)
  • People who currently smoke
  • People who are pregnant
  • People who have taken antibiotics or stomach acid-reducing medications (proton pump inhibitors) in the last 3 months
  • People who take antioxidant supplements or regularly consume beetroot or nitrate supplements
  • People whose health is currently unstable, including those with unstable chest pain, irregular heart rhythms, a serious heart condition, a recent acute illness in the last month, or poorly controlled blood sugar levels
  • People who are unable to exercise — for example, due to amputation without a prosthesis, muscle or joint pain at rest or with minimal movement, inability to sit or walk without help, use of a walking aid, or breathlessness at rest or with light activity
  • People who have autoimmune diseases, infectious diseases, cancer, liver disease, or AIDS
  • People whose parathyroid hormone (PTH) levels are above 500 pg/mL (a specific hormone level measured by a blood test)
  • People who are allergic or intolerant to any ingredients in the juice used in the trial
  • People who may not be able to complete the full exercise program due to travel difficulties or problems getting to the research location

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Denise Mafra, PhD, Associate Professor - Universidade Federal Fluminense

Phone: +5521985683003

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidade Federal Fluminense
Registry
ClinicalTrials.gov
Start date
10 April 2024
Est. completion
10 November 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Change individual quality of life; Change physical activity level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov